I agree the potential is staggering but why would a company pay a considerable upfront payment and royalties on a deal when It can take over the company at a fraction of the outlay?
Can anyone explain why good experimental news on the covid treatment lead to the massive gains so me expect when phase 1 trials have not even started yet?